AU2001226233A1 - A medicinal aerosol formulation - Google Patents
A medicinal aerosol formulationInfo
- Publication number
- AU2001226233A1 AU2001226233A1 AU2001226233A AU2623301A AU2001226233A1 AU 2001226233 A1 AU2001226233 A1 AU 2001226233A1 AU 2001226233 A AU2001226233 A AU 2001226233A AU 2623301 A AU2623301 A AU 2623301A AU 2001226233 A1 AU2001226233 A1 AU 2001226233A1
- Authority
- AU
- Australia
- Prior art keywords
- aerosol formulation
- medicinal aerosol
- medicinal
- formulation
- aerosol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20105800P | 2000-05-01 | 2000-05-01 | |
US60201058 | 2000-05-01 | ||
US09703068 | 2000-10-31 | ||
US09/703,068 US6447750B1 (en) | 2000-05-01 | 2000-10-31 | Medicinal aerosol formulation |
PCT/US2001/000032 WO2001082872A2 (en) | 2000-05-01 | 2001-01-02 | A medicinal aerosol formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001226233A1 true AU2001226233A1 (en) | 2001-11-12 |
Family
ID=26896351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001226233A Abandoned AU2001226233A1 (en) | 2000-05-01 | 2001-01-02 | A medicinal aerosol formulation |
Country Status (3)
Country | Link |
---|---|
US (2) | US6447750B1 (en) |
AU (1) | AU2001226233A1 (en) |
WO (1) | WO2001082872A2 (en) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010031244A1 (en) * | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
US20060171899A1 (en) * | 1998-12-10 | 2006-08-03 | Akwete Adjei | Water-stabilized aerosol formulation system and method of making |
US7074388B2 (en) * | 1998-12-10 | 2006-07-11 | Kos Life Science, Inc. | Water stabilized medicinal aerosol formulation |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
US6447750B1 (en) * | 2000-05-01 | 2002-09-10 | Aeropharm Technology Incorporated | Medicinal aerosol formulation |
WO2002089916A1 (en) * | 2001-05-04 | 2002-11-14 | Pfizer Products Inc. | Method of preventing type 2 diabetes with aerosolized insulin |
EP1487407A4 (en) * | 2002-03-12 | 2010-08-25 | Microdose Therapeutx Inc | Site specific delivery of co-administered drugs via inhalation |
DE60318938T2 (en) | 2002-03-20 | 2009-01-22 | Mannkind Corp., Valencia | INHALER |
US20080260838A1 (en) * | 2003-08-01 | 2008-10-23 | Mannkind Corporation | Glucagon-like peptide 1 (glp-1) pharmaceutical formulations |
US7655618B2 (en) * | 2002-12-27 | 2010-02-02 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
US7683029B2 (en) * | 2003-05-07 | 2010-03-23 | Philip Morris Usa Inc. | Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating aerosolized insulin |
WO2005065654A2 (en) * | 2003-12-31 | 2005-07-21 | Alpharma, Inc. | Rosiglitazone formulations |
US20050163842A1 (en) * | 2003-12-31 | 2005-07-28 | Garth Boehm | Rosiglitazone and metformin formulations |
EP1786784B1 (en) | 2004-08-20 | 2010-10-27 | MannKind Corporation | Catalysis of diketopiperazine synthesis |
CA2578175C (en) | 2004-08-23 | 2014-10-14 | Mannkind Corporation | Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery |
US7803404B2 (en) | 2005-09-14 | 2010-09-28 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
BRPI0707991B8 (en) | 2006-02-22 | 2021-05-25 | Mannkind Corp | methods of preparing a dry powder medicine with an improved pharmaceutical property, said dry powder and using an effective amount of the dry powder |
US7967873B1 (en) | 2006-03-29 | 2011-06-28 | Bozzetto, Inc. | Dyed textile article and dye bath assistant |
CN101969927A (en) * | 2007-10-24 | 2011-02-09 | 曼金德公司 | Method of preventing adverse effects by glp-1 |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
EP2570147B1 (en) | 2008-06-13 | 2017-10-18 | MannKind Corporation | A dry powder inhaler and system for drug delivery |
US9364619B2 (en) | 2008-06-20 | 2016-06-14 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
TWI614024B (en) | 2008-08-11 | 2018-02-11 | 曼凱公司 | Use of ultrarapid acting insulin |
WO2010065843A2 (en) | 2008-12-05 | 2010-06-10 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Biologic scaffold for prevention of pulmonary fibrosis |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
PL2405963T3 (en) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Apparatus, system and method for measuring resistance of an inhaler |
KR20180079458A (en) | 2009-06-12 | 2018-07-10 | 맨카인드 코포레이션 | Diketopiperazine microparticles with defined specific surface areas |
EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
RU2531455C2 (en) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Systems and methods for dry powder drugs delivery |
EP2683489A4 (en) * | 2011-03-11 | 2015-08-12 | Guisheng Yang | Magnetic particle scavenging device and method |
TWI399202B (en) | 2011-03-17 | 2013-06-21 | Intech Biopharm Ltd | The preparation for formulation composition and manufacturing processes of metered dose inhalers treated respiratory diseases |
CN105667994B (en) | 2011-04-01 | 2018-04-06 | 曼金德公司 | Blister package for pharmaceutical kit |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
AU2012328885B2 (en) | 2011-10-24 | 2017-08-31 | Mannkind Corporation | Methods and compositions for treating pain |
CN108057154B (en) | 2012-07-12 | 2021-04-16 | 曼金德公司 | Dry powder drug delivery system and method |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
CA2906817C (en) | 2013-03-15 | 2022-01-18 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
US9925144B2 (en) | 2013-07-18 | 2018-03-27 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
JP2016530930A (en) | 2013-08-05 | 2016-10-06 | マンカインド コーポレイション | Ventilation device and method |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5439670A (en) | 1989-11-28 | 1995-08-08 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
HU222249B1 (en) * | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Process for producing amyline antagonistic peptide derivatives and pharmaceutical preparatives containing them |
GB9202519D0 (en) | 1992-02-06 | 1992-03-25 | Glaxo Group Ltd | Medicaments |
ATE264096T1 (en) * | 1994-03-07 | 2004-04-15 | Nektar Therapeutics | METHOD AND MEANS FOR ADMINISTERING INSULIN VIA THE LUNGS |
US6261539B1 (en) * | 1998-12-10 | 2001-07-17 | Akwete Adjei | Medicinal aerosol formulation |
US6447750B1 (en) * | 2000-05-01 | 2002-09-10 | Aeropharm Technology Incorporated | Medicinal aerosol formulation |
-
2000
- 2000-10-31 US US09/703,068 patent/US6447750B1/en not_active Expired - Lifetime
-
2001
- 2001-01-02 WO PCT/US2001/000032 patent/WO2001082872A2/en active Application Filing
- 2001-01-02 AU AU2001226233A patent/AU2001226233A1/en not_active Abandoned
-
2002
- 2002-07-09 US US10/191,123 patent/US6645468B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6645468B2 (en) | 2003-11-11 |
WO2001082872A3 (en) | 2002-01-24 |
WO2001082872A2 (en) | 2001-11-08 |
US20030012739A1 (en) | 2003-01-16 |
US6447750B1 (en) | 2002-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001224716A1 (en) | A medicinal aerosol formulation | |
AU2001226233A1 (en) | A medicinal aerosol formulation | |
AU2753001A (en) | A medicinal aerosol formulation | |
EP1296723A4 (en) | A medicinal aerosol formulation | |
AU4519001A (en) | A medicinal aerosol formulation | |
AU2002218250A1 (en) | Medicament dispenser | |
AU6310000A (en) | Aerosol formulations | |
IL155088A0 (en) | Medicinal aerosol formulations | |
AU2002223562A1 (en) | Medicament dispenser | |
AUPR054400A0 (en) | A castor | |
AU2001227535A1 (en) | A core formulation | |
AU2001227532A1 (en) | A core formulation | |
AU2001224718A1 (en) | A medicinal aerosol formulation | |
AU2623401A (en) | A medicinal aerosol formulation | |
AUPR000900A0 (en) | A berley dispenser | |
AU2001259318A1 (en) | A medicinal aerosol formulation | |
AU1141101A (en) | Pharmaceutical aerosol formulations comprising s-salmeterol | |
HUP0600143A2 (en) | A stable pharmaceutical formulation comprising torsemide modification ii | |
AU2001247123A1 (en) | A medicinal aerosol formulation | |
AU2001227531A1 (en) | A medicinal aerosol formulation | |
EP1292283A4 (en) | A medicinal aerosol formulation | |
AU2001272718A1 (en) | Medicaments | |
AU2002215902A1 (en) | Medicament dispenser | |
GB0014849D0 (en) | Pharmaceutical aerosol formulation | |
AU2002223437A1 (en) | Medicament dispenser |